Literature DB >> 9642513

Apoptosis and hepatic allograft reperfusion injury.

P C Kuo1, C I Drachenberg, A de la Torre, S T Bartlett, J W Lim, J S Plotkin, L B Johnson.   

Abstract

Necrosis and apoptosis are distinct, but nonexclusive mechanisms of cell death. Until recently, investigators have focused upon necrosis as the sine qua non of lethal cell injury. Specifically, within the realm of liver transplantation, preservation strategies dealing with ischemia/reperfusion injury have concentrated upon minimizing the biochemical and histologic correlates associated with necrosis. Little is known of the role of apoptosis in reperfusion injury in human liver transplantation. Post-reperfusion liver biopsies from 35 patients were retrospectively analyzed for histologic evidence of necrosis. Apoptosis was identified histologically and using a chromogenic technique of in situ labeling of fragmented DNA. The number of apoptotic cells increased in parallel with the necrosis reperfusion score in a significant fashion (p = 0.003 by ANOVA). There was not a Zone 1, 2 or 3 predominance to the histologic distribution of apoptotic cells. The recipient peak serum transaminase values were also noted to increase with the reperfusion score (p = 0.001 by ANOVA). These results suggest that: 1) apoptosis occurs in the setting of reperfusion injury during human orthotopic liver transplantation (OLT); and 2) the extent of apoptosis increases in parallel with pathologic and biochemical parameters of reperfusion injury. Given the distinct nature of apoptosis and the highly regulated and conserved pathway for its initiation, inhibition of apoptosis with specific molecular targets, may serve to decrease allograft reperfusion injury.

Entities:  

Mesh:

Year:  1998        PMID: 9642513

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  7 in total

1.  Sulforaphane reduces apoptosis and oncosis along with protecting liver injury-induced ischemic reperfusion by activating the Nrf2/ARE pathway.

Authors:  Xinjin Chi; Rui Zhang; Ning Shen; Yi Jin; Ayep Alina; Simin Yang; Shiqing Lin
Journal:  Hepatol Int       Date:  2015-01-25       Impact factor: 6.047

2.  Is there still a need for living-related liver transplantation in children?

Authors:  D C Broering; L Mueller; R Ganschow; J S Kim; E G Achilles; H Schäfer; M Gundlach; L Fischer; M Sterneck; C Hillert; K Helmke; J R Izbicki; M Burdelski; X Rogiers
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

3.  Amifostine enhances the antioxidant and hepatoprotective effects of UW and HTK preservation solutions.

Authors:  Sami Akbulut; Sinasi Sevmis; Hamdi Karakayali; Nilüfer Bayraktar; Muge Unlukaplan; Ergun Oksuz; Atilla Dagdeviren
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 4.  Apoptosis and necroptosis in the liver: a matter of life and death.

Authors:  Robert F Schwabe; Tom Luedde
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-12       Impact factor: 46.802

Review 5.  Apoptosis and necrosis in the liver.

Authors:  Maria Eugenia Guicciardi; Harmeet Malhi; Justin L Mott; Gregory J Gores
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

6.  Impact of fluid therapy on apoptosis and organ injury during haemorrhagic shock in an oxygen-debt-controlled pig model.

Authors:  S C Rehberg; M R Raum; S Rammelt; W Schneiders; E A M Neugebauer
Journal:  Eur J Trauma Emerg Surg       Date:  2013-06-04       Impact factor: 3.693

7.  Adipose-derived stem cells alleviate liver apoptosis induced by ischemia-reperfusion and laparoscopic hepatectomy in swine.

Authors:  Yansong Ge; Qianzhen Zhang; Hui Li; Ge Bai; Zhihui Jiao; Hongbin Wang
Journal:  Sci Rep       Date:  2018-11-15       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.